Immunomodulatory effect of Bacillus toyonensis BCT-7112 supplementation in puppies vaccinated against canine parvovirus / Efeito imunomodulador da suplementação de Bacillus toyonensis BCT-7112 em cachorros vacinados contra o parvovírus canino

Bacillus toyonensis is a probiotic microorganism that for decades has been used in animal nutrition around the world. The objective of this work was to evaluate the immunomodulatory effect of oral B. toyonensis supplementation in dogs vaccinated against canine parvovirus. Puppies were randomly selected and divided in two groups, one received B. toyonensis at a concentration of 2x10 8 viable spores per day and another group without supplementation was left as control. The puppies were vaccinated against canine parvovirus type 2. B. toyonensis supplementation was efficient in stimulating specific IgG for parvovirus with titers of 2, 3, and 2.5-fold higher than controls at 7, 21, and 35 pos-vaccination days respectively. Peripheral blood mononuclear cells (PBMCs) from dogs were cultured and stimulated with B. toyonensis DNA, vegetative cell and spores. The mRNA transcription of cytokines IL-4, IL-17, and IFN-γ up modulated by the stimuli. Thus, we conclude in this study that B. toyonensis supplementation may amplify the vaccine immune response against canine parvovirus.(AU)

Bacillus toyonensis é um micro-organismo probiótico que há décadas é utilizado na nutrição animal em todo o mundo. O objetivo deste trabalho foi avaliar o efeito imunomodulador da suplementação oral de B. toyonensis em cães vacinados contra o parvovírus canino. Os filhotes foram selecionados aleatoriamente e divididos em dois grupos, um recebeu B. toyonensis na concentração de 2 × 10 8 esporos viáveis por dia e outro grupo sem suplementação como controle. Os filhotes foram vacinados contra o parvovírus canino tipo 2. A suplementação com B. toyonensis foi eficiente em estimular IgG específica para parvovírus com títulos de 2, 3 e 2,5 vezes maior que os controles aos 7, 21 e 35 dias pós-vacinação, respectivamente. Células mononucleares do sangue periférico (PBMCs) de cães foram cultivadas e estimuladas com DNA de B. toyonensis, células vegetativas e esporos. A transcrição do mRNA das citocinas IL-4, IL-17 e IFN-γ foi modulada pelos estímulos. Assim, concluímos neste estudo que a suplementação com B. toyonensis pode amplificar a resposta imune da vacina contra o parvovírus canino.(AU)

Study of Different Risk Factors for Canine Parvovirus infection by Haemagglutination Assay

Haemorrhagic gastroenteritis in canine is caused by different etiological agents like canine parvovirus, E.coli, Salmonella, Campylobacter, Coccidia and Giardia, among these agents canine parvovirus is the most important. Canine parvovirus binds to the sialic acid receptors which are present on the RBC’s, so haemagglutination test is used to detect canine parvovirus. In this study a total (n=102) of faecal samples from canines having haemorrhagic gastroenteritis were taken. All the 102 samples were subjected to haemagglutination assay and the prevalence of CPV was studied. Host associated risk factors like age, sex, breed, vaccination and seasons responsible for occurrence of canine parvovirus infection are recorded. Out of the 102 samples haemagglutination assay detected 41 samples as positive and a percent positivity of (40.19%) was recorded by this diagnostic test. Age wise prevalence was (69.23%) in (0-6 month) age group which is more than (7-12 month) (13.33%) and more than a year group (5%). Sex wise prevalence was more in males (47.94%) than in females (20.78%). Breed wise prevalence was more in Labrador (78.57%) followed by Doberman Pinscher (62.50%) lower prevalence was reported in Pomerarian and German shephered breeds. Non vaccinated canines showed a high prevalence of (42.70%) and in vaccinated canines no disease prevalence was detected. In the season wise prevalence, spring season showed more prevalence (54.76%) followed by summer season which showed (37.5%) prevalence and the least prevalence of (11.11%) was recorded in the winter season. Study showed that Haemagglutination assay is a good diagnostic test for the study of canine parvovirus where modern facilities of molecular diagnosis and the costly faecal ELISA test kits are not available.

Lontra longicaudis infected with canine parvovirus and parasitized by Dioctophyma renale / Lontra longicaudis de vida livre infectada por parvovirus canino e parasitada por Dioctophyma renale

This study describes a case of parvovirus infection in a river otter (Lontra longicaudis) assisted at the Wildlife Rehabilitation Center and Wildlife Screening Center, Federal University of Pelotas (UFPel), Rio Grande do Sul state, Brazil. Clinical signs included apathy, dark and fetid diarrhea, and crusted lesions on the palmar pads of the fore and hind limbs. The animal died after undergoing support treatment with antibiotics, anti-inflammatory, and fluid therapy. At necropsy, the intestines were reddened and edematous and the right kidney was diminished by one third of its normal size and covered with whitish, spongy material. A female Dioctophyma renale was found free in the abdominal cavity. Histologically, dilatation of the intestinal crypts and fusion and blunting of the intestinal villi were observed. In addition, moderate, multifocal lymphocytic enteritis with lymphoid depletion in Peyer's patches and mesenteric lymph nodes were present. Immunohistochemistry with anti-canine parvovirus monoclonal antibody (anti-CPV) was strongly positive in the bone marrow cells and enterocytes of the intestinal crypts, confirming the diagnosis of parvovirus infection. The peritoneum on the right kidney was expanded with a cuboidal cell border, forming multiple papillary projections associated with eggs of D. renale and severe inflammatory infiltrate (giant cells, macrophages, lymphocytes, eosinophils, and plasma cells). Areas of necrosis and mineralization were also observed. Due to fragmentation and degradation of its natural habitat, the otter approached the urban area and was contaminated with the virus, which is hosted and disseminated by domestic animals. Infection with D. renale can be associated with the large population of parasitized domestic animals, which eliminate the helminth eggs through urine, contaminating the environment where the parasite intermediate and paratenic hosts co-inhabit. The diseases of these animals can be a decline factor of wild populations that inhabit the region and are an alert to spillover risk.(AU)

Descreve-se um caso de parvovirose em uma lontra (Lontra longicaudis) enviada ao Núcleo de Reabilitação da Fauna Silvestre e Centro de Triagem de Animais Silvestres da Universidade Federal de Pelotas, Rio Grande do Sul, Brasil. O animal estava debilitado, apático, apresentava diarreia escura e fétida e lesões crostosas nos coxins palmares dos membros torácicos e pélvicos, morrendo após tratamento de suporte com antibiótico, anti-inflamatório e fluidoterapia. Na necropsia os intestinos estavam edematosos e avermelhados e o rim direito estava recoberto de material brancacento e esponjoso, com comprometimento de cerca de um terço do órgão. Foi observado, também, um exemplar de Dioctophyma renale, fêmea, livre na cavidade abdominal. Histologicamente havia fusionamento das vilosidades, dilatação das criptas intestinais com enterite linfocítica moderada multifocal e depleção linfoide nos linfonodos mesentéricos. Na técnica de imuno-histoquímica (IHQ) com anticorpo monoclonal anti-Parvovírus canino (Anti-CPV) houve marcação positiva nos enterócitos da base das vilosidades intestinais e na medula óssea, confirmando o diagnóstico de parvovirose. O peritônio sobre o rim direito estava espessado e revestido por células cuboides, formando múltiplas projeções papilares, nas quais observava-se acentuado infiltrado de células gigantes, macrófagos, linfócitos, eosinófilos e plasmócitos. Entre as projeções papilares havia ovos de Dioctophyma renale, áreas de necrose, calcificação e células gigantes. Conclui-se que a lontra, em função da fragmentação e degradação de seu habitat natural, aproximou-se do centro urbano e contaminou-se com o vírus, o qual é mantido e disseminado por animais domésticos. Por sua vez, a infecção por D. renale pode estar relacionada com a presença de animais domésticos parasitados, os quais eliminam ovos do helminto através da urina contaminando o ambiente, onde coabitam hospedeiros intermediários e paratênicos do parasito. As doenças desses animais podem ser um fator de declínio das populações de animais silvestres e alerta para o risco de spill-over na região.(AU)

Epidemiological, clinical and pathological features of canine parvovirus 2c infection in dogs from southern Brazil / Aspectos epidemiológicos, clínicos e patológicos da infecção pelo parvovirus canino 2c em cães do Sul do Brasil

Canine parvovirus type 2c (CPV-2c) emerged in Europe in the early 2000's and rapidly spread out worldwide. Clinical and molecular data have demonstrated its circulation in Brazilian dogs, yet detailed descriptions of cases are still lacking. This article describes the epidemiological, clinical and pathological features of 24 cases of CPV-2c-associated disease in dogs submitted to veterinary clinics and laboratory diagnosis in southern Brazil (2014-2016). Most affected dogs presented signs/lesions suggestive of parvovirus enteritis: diarrhea, vomiting, hyperemia and hemorrhage of the serous membrane of the small intestine, diffuse segmental granulation, atrophy of the villi, necrosis and fusion of crypts, squamous metaplasia and epithelial syncytia. A number of cases presented features divergent from the classical presentations, including a wide variation in the color of feces (reddish and/or yellowish, light-brownish, orange-brown and brownish), involvement of adults (4/24) and vaccinated dogs (12/24), extensive involvement of the small intestine (8/20) and the presence of pulmonary edema (7/24) and convulsions (3/24). Feces and intestinal fragments submitted to PCR for the CPV-2 VP2 gene and to virus isolation in cell culture yielded positive results in 100% and 58.3% (14/24) of the cases, respectively. Nucleotide sequencing revealed a high nucleotide identity in VP2 (99.4 to 100%) and a consistent mutation at amino acid 426 (asparagine to glutamic acid), considered a signature of CPV-2c. These results confirm the involvement of CPV-2c in the described cases and demonstrate the importance of CPV-2c infection among Brazilian dogs, calling attention of veterinarians to correctly diagnose the disease, mainly considering the frequent atypical presentations.(AU)

O parvovírus canino tipo 2c (CPV-2c) surgiu na Europa no início do ano 2000 e rapidamente se espalhou pelas populações de cães ao redor do mundo. Dados clínicos e moleculares demonstraram a sua circulação em cães brasileiros, porém descrições detalhadas desses casos ainda são escassas. Este artigo descreve os aspectos epidemiológicos, clínicos e patológicos de 24 casos de doença gastroentérica associada com a infecção pelo CPV-2c em cães atendidos em clínicas veterinárias e submetidos ao diagnóstico laboratorial no Sul do Brasil (2014-2016). A maioria dos cães afetados apresentaram sinais e/ou lesões sugestivas de enterite por parvovírus: diarreia, vômitos, hiperemia e hemorragia na membrana serosa do intestino delgado, granulação segmentar difusa, atrofia das vilosidades, necrose e fusão de criptas, metaplasia escamosa e sincícios epiteliais. Alguns casos apresentaram características divergentes das apresentações clássicas, incluindo uma grande variação na cor das fezes (avermelhada e/ou amarelada, marrom-claro, marrom-alaranjada ou amarronzada), a participação dos adultos (4/24) e cães vacinados (12/24), um amplo envolvimento do intestino delgado (8/20), a presença de edema pulmonar (7/24) e convulsões (3/24). As fezes e fragmentos intestinais foram submetidos ao teste de PCR para o gene VP2 do CPV-2, e ao isolamento do vírus em cultura de células produziram resultados positivos em 100% e 58,3% (14/24) dos casos, respectivamente. O sequenciamento dos nucleótidos revelou uma alta identidade de nucleótidos na VP2 (99,4-100%) e uma mutação no aminoácido 426 (asparagina para ácido glutâmico), considerada uma assinatura de CPV-2c. Estes resultados confirmam o envolvimento do CPV-2c nos casos descritos e demonstra a importância da infecção pelo CPV-2c entre os cães do Brasil, chamando a atenção de veterinários para diagnosticar corretamente a doença, principalmente considerando-se as apresentações atípicas frequentes.(AU)

Viral type characterization and clinical aspects of canine parvovirus in naturally infected dogs in São Paulo State, Brazil / Caracterização viral e aspectos clínicos de parvovirose em cães naturalmente infectados no Estado de São Paulo

Since the first isolation of canine parvovirus type 2 (CPV-2) in late 70's new virus types as CPV-2a and CPV-2b have been emerged and becoming prevalent in natural canine population and more recently, a third subtype was identified , CPV-2c. The main purpose of this study was to detect and characterize canine parvovirus currently present in Central-West region of São Paulo state, in Brazil. Fecal samples were collected of vaccinated and non-vaccinated dogs, clinically suspected of having CPV infection brought to the Infectious Diseases Service, Veterinary Hospital of FMVZ-UNESP. All samples (n=30) were screening for canine parvovirus through hemagglutination test and those resulting as positive (n=20) were submitted to PCR and the products were subsequently sequenced for subtype characterization. Results were tested for association with age, hematological values, viral hemagglutination titers in the feces, vaccination status and survival. Leukopenia was found in all animals, death occurred in 30% of unvaccinated dogs and in 42% of vaccinated ones. In a total of 20 positive sequenced samples, 18 were classified as CPV-2b, one as CPV-2c, and one as CPV-2a, being CPV2a and CPV2c detected in unvaccinated puppies. Compared to the reference samples amino acid change at position 426 in those circling virus was identified. The study results demonstrate the predominance of CPV-2b and the presence of CPV-2a and CPV-2c in naturally infected, vaccinated and unvaccinated dogs in in São Paulo region.(AU)

Desde o primeiro isolamento do parvovirus canino tipo 2 (CPV-2) no final dos anos 70 novos subtipos virais como CPV-2a e CPV-2b surgiram e foram se tornando prevalentes na população canina; posteriormente um terceiro subtipo foi identificado, CPV- 2-C. O principal objetivo deste estudo foi detectar e caracterizar os subtipos de parvovírus canino atualmente presente na região Centro-Oeste do Estado de São Paulo-Brasil. Amostras de fezes foram coletadas de cães vacinados e não vacinados, atendidos no Serviço de Enfermidades Infecciosas dos Animais, Hospital Veterinário da FMVZ-UNESP, com suspeita clínica parvovirose . Todas as amostras (n = 30) foram submetidas teste de hemaglutinação para parvovirus canino e as positivas (n = 20) submetidas a PCR; os produtos amplificados foram subsequentemente sequenciados para caracterização do subtipo viral. Os resultados foram associados com a idade, os valores hematológicos, os títulos de hemaglutinação viral nas fezes, estado de vacinação e sobrevivência. A leucopenia foi encontrada em todos os animais; Obito foi observado em 30% dos cães não vacinados e 42% dos vacinados. Em um total de 20 amostras positivas sequenciadas, 18 foram classificadas como CPV-2b, uma como CPV-2c, e uma como CPV-2a. CPV 2a e CPV2c foram detectados em filhotes não vacinados. Em comparação com a amostra de referência foi evidenciada uma mudança de aminoácido na posição 426 nas amostras virais circulantes. Os resultados do estudo demonstram a predominância de CPV-2b e a presença de CPV-2a e CPV-2c em cães naturalmente infectados, vacinados e não vacinados na região de São Paulo.(AU)

Characterization and evaluation of apoptotic potential of double gene construct pVIVO.VP3.NS1.

Viral gene oncotherapy, targeted killing of cancer cells by viral genes, is an emerging non-infectious therapeutic cancer treatment modality. Chemo and radiotherapy in cancer treatment is limited due to their genotoxic side effects on healthy cells and need of functional p53, which is mutated in most of the cancers. VP3 (apoptin) of chicken infectious anaemia (CIA) and NS1 (Non structural protein 1) of Canine Parvovirus-2 (CPV-2) have been proven to have oncolytic potential in our laboratory. To evaluate oncolytic potential of VP3 and NS1 together these genes needed to be cloned in a bicistronic vector. In this study, both these genes were cloned and characterized for expression of their gene products and its apoptotic potential. The expression of VP3 and NS1 was studied by confocal microscopy and flowcytometry. Expression of VP3 and NS1 in pVIVO.VP3.NS1 transfected HeLa cells in comparison to mock transfected cells indicated that the double gene construct expresses both the products. This was further confirmed by flowcytometry where there was increase in cells expressing VP3 and NS1 in pVIVO.VP3.NS1 transfected group in comparison with the mock control group. The apoptotic inducing potential of this characterized pVIVO.VP3.NS1 was evaluated in human cervical cancer cell line (HeLa) by DNA fragmentation assay, TUNEL assay and Hoechst staning. This double construct was observed to induce apoptosis in HeLa cells.

A phylogenetic study of canine parvovirus type 2c in midwestern Brazil / Estudo filogenético do parvovírus canino tipo 2c no Centro-Oeste do Brasil

Since the late 1970s, canine parvovirus type 2 (CPV-2) has emerged as a causative agent of fatal severe acute hemorrhagic enteritis in dogs. To date, three antigenic types of CPV-2 were described worldwide (CPV-2a/b/c). This study was conducted to determine the variants of CPV-2 circulating in dogs from the Cuiabá Municipality in Midwestern Brazil. Out of 50 fecal samples, collected between 2009 and 2011, 27 tested positive for CPV-2. A 583 bp fragment of the VP2 gene was amplified by PCR, 13 representative samples were analyzed further by DNA sequencing. All strains were characterized as CPV-2c, displayed a low genetic variability although observed several amino acid substitution. These findings indicated that CPV-2c has been circulating in dogs from the Cuiabá Municipality in Midwestern Brazil.

Desde o final dos anos de 1970, o parvovírus canino tipo 2 (CPV-2) tem emergido como agente de severa e fatal enterite hemorrágica, principalmente em cães com idade inferior a seis meses. Três variantes antigênicas de CPV-2 foram descritas mundialmente (CPV-2a/b/c). O objetivo do estudo foi determinar a presença do CPV-2 e suas variantes circulantes em cães no Município de Cuiabá, Centro-oeste, Brasil. Das 50 amostras fecais, coletadas entre 2009 e 2011, 27 foram positivas para CPV-2 na PCR, sendo 13 analisadas pelo sequenciamento de um fragmento de 583 pares de base do gene VP2. Todas as cepas foram caracterizadas como CPV-2c e apresentaram baixa variabilidade genética. Estes achados indicaram que o CPV-2c está circulando na população canina do Município de Cuiabá, Região Centro-Oeste do Brasil.

Comparison of three laboratorial tests for diagnosis of canine parvovirus infection / Comparação de três testes laboratoriais para diagnóstico da infecção pelo parvovírus canino

The aim of this study was to evaluate the rapid tests currently used for canine parvovirus (CPV) diagnosis: hemagglutination test (HA), enzyme immunoassay (EIA) and polymerase chain reaction (PCR). A total of 112 fecal samples collected from diarrheic puppies up to one year of age were tested. The EIA was able to detect CPV antigen in 44 samples. By HA, 32 samples tested highly positive with titers >128, eight tested weakly positive (titers 32 and 64) and 72 were negative (titers <16). Using PCR, 57 samples were found positive including 13 EIA-negative and 19 HA-negative samples. The best correlation was observed between EIA and PCR (88.4%). These tests were able to detect all types of CPV, including CPV-2c. Considering that 23%-33% of dogs presenting enteritis did not show infection by EIA nor HA, negative results from the antigen detection tests should be confirmed through molecular methods.

Avaliaram-se os métodos rápidos rotineiramente utilizados para diagnóstico da infecção por parvovírus canino (CPV): teste de hemaglutinação (HA), ensaio imunoenzimático (EIE) e reação em cadeia pela polimerase (PCR). Um total de 112 amostras fecais de cães diarreicos com até um ano de idade foi testado. O EIE foi capaz de detectar o antígeno do CPV em 44 amostras. Por HA, 32 amostras foram consideradas fortemente positivas com títulos >128, oito fracamente positivas (títulos 32 e 64) e 72 negativas (títulos <16). Por PCR, 57 amostras foram positivas incluindo 13 EIE-negativas e 19 HA-negativas. A melhor correlação foi observada entre EIE e PCR (88,4%). Os testes foram capazes de detectar todos os tipos de CPV, incluindo o CPV-2c. Considerando-se que em 23%-33% dos filhotes com enterite a infecção por CPV não foi diagnosticada pelos testes de EIE e HA, os resultados negativos nos testes de detecção de antígeno devem ser confirmados por meio de métodos moleculares.

Immunogenicity of a Canine Parvovirus 2 Capsid Antigen (VP2-S1) surface-expressed on Lactobacillus casei / 동물의과학연구지

Canine parvovirus (CPV2) is one of the most virulent virus causing acute hemorrhagic enteritis and myocarditis in dogs. Infection mainly caused by the ingestion of virus through the mucosal route. Therefore, induction of mucosal immunity is essential in prevention of Canine Parvovirus (CPV2) infection. For safe and effective delivery of viral antigens to the mucosal immune system, a novel surface antigen display system for lactic acid bacteria using the poly-gamma-glutamic acid synthetase A protein (pgsA) of Bacillus subtilis as an anchoring matrix was applied in order to display CPV2 antigen on the surface of the recombinant L. casei. Recombinant fusion proteins comprised of pgsA and the capsid protein (VP2-S1) showed stable expression in Lactobacillus casei. Surface localization of the fusion protein was verified by cellular fractionation analyses. Oral and nasal inoculations of recombinant L. casei into mice resulted in high levels of serum immunoglobulin G (IgG) and mucosal IgA, as demonstrated by ELISA using recombinant VP2-S1 proteins. Mice receiving intranasal immunization mounted higher antibody response than those receiving oral immunization. These results indicate that mucosal immunization with recombinant L. casei expressing CPV2 VP2-S1 protein on its surface provides an effective means for elicitation of strong antibody responses against CPV 2 VP2-S1.

Isolation and characterization of canine parvovirus type 2c (CPV-2c) from symptomatic puppies

Canine parvovirus type 2 (CPV-2) is a leading cause of diarrhea in puppies in several parts of the world. In this study CPV-2 was detected and recovered from puppies showing clinical disease from Montevideo, Uruguay. Samples were processed and used to infect CRFK and MDCK cells in order to isolate the virus. Out of twelve, two samples were positive for CPV-2. A genomic region of 583 bp was amplified and the molecular characterization was performed by sequencing, phylogenetic analysis and Restriction Fragment Length Polymorphism (RFLP). Two isolated viruses (UY1 and UY2) were CPV-2c-like viruses. The comparison between the cytophatic effect (CPE) of CPV-2 (vaccinal virus) and CPV-2c (isolated virus) on primary canine cells cultures and on CRFK line cells, demonstrated that CPV-2c is less citopathogenic in CRFK than in primary cultures. Our study represents the first report on isolation and characterization of canine parvovirus type 2c (CPV-2c) in cell cultures from South American dogs.

Effect of the ethanolic extract from green propolis on production of antibodies after immunization against canine parvovirus (CPV) and canine coronavirus (CCoV) / Efeito do extrato etanólico de própolis verde sobre a produção de anticorpos após imunização contra parvovírus canino (CPV) e coronavírus canino (CCoV)

This study was designed to evaluate whether an ethanolic extract of green propolis (EEP) can interfere with p roduction of specific antibodies after immunization against parvovirus (CPV) and canine coronavirus (CCoV). Mice were vaccinated with CPV and CCoV (0.75, 1.5 and 3 x 106 TCID50) with or without 400 μg/dose of the EEP. Twenty one days after the third dose was measured serum IgG. The co-administration of the EEP significantly enhanced serum specific IgG responses to CPV in animals inoculated with the highest concentration of the antigen, and had no influence on levels of antibodies to CCoV. The results indicate that the EEP has immunomodulatory action closely dependent on the type and concentration of antigen used, being able to increase the levels of antibodies to CPV.

Este estudo foi realizado para avaliar se extrato etanólico de própolis verde (EEP) pode interferir na produção de anticorpos específicos após imunização contra parvovírus (CPV) e coronavírus canino (CCoV). Camundongos foramvacinados com CPV e CCoV (0.75, 1.5 e 3 x 106 TCID50) com ou sem 400 μg/dose de EEP. Vinte e um dias após a terceira dose foi mensurado IgG sérica. A coadministração de EEP aumentou significativamente os níveis de IgG específica para o CPV em animais inoculados com a maior concentração do antígeno, e não teve influência sobre os níveis de anticorpos para CCoV. Os resultados indicam que o EEP tem ação imunomoduladora intimamente dependente do tipo e concentração do antígeno utilizado, sendo capaz de aumentar os níveis de anticorpos contra CPV.

Characterization and in vitro expression of non-structural 1 protein of canine parvovirus (CPV-2) in mammalian cell line.

Parvoviruses are small, 260-Å-diameter, icosahedral, non-enveloped, single-stranded DNA viruses with a genome of approximately 5 kb. Non structural protein, (NS-1) is especially relevant, being both essential for virus replication and the main factor responsible for virus pathogenicity and cytotoxicity. This protein has also been reported to possess the property of killing of transformed cells. The present study was carried out to clone, characterize and express the NS-1 gene of canine parvovirus. NS-1 complete CDS 2020bp was amplified, cloned into eukaryotic expression vector pcDNA 3.1(+), sequenced and characterized by in vitro expression analysis. Functional activity of recombinant construct, pcDNA.cpv.NS-1, was evaluated by RT-PCR and flow cytometry for the expression of NS-1 specific mRNA and NS-1 protein, respectively, in transfected HeLa cells. This recombinant plasmid may serve as an important tool to evaluate the apoptotic potential of NS-1 protein of canine parvovirus in cultured HeLa cells.

Canine parvovirus gene grow in E.Coli using molasses medium which can be use as a vaccine.

The Canine parvovirus gene is inserted in E.coli (DH5α) strain. Grow the recombinant E. coli for the plasmid DNA using molasses medium to make the vaccine. During the initial studies I have found that the molasses can manipulate the C/N ratio as per requirement of cell. Molasses is one of the best alternatives as it is cheap and can be easily manipulated. During the experiment the O.D of culture and O.D of plasmid DNA was observed in respective of different optimization method. I observed that the O.D value has increase to i.e. 2.129, as it was earlier i.e. 0.393. The quality and quantity of the plasmid DNA was very good. It is possible to produce vaccine by molasses medium. The paper is opening a new face of study.

Exposure of pampas fox (Pseudalopex gymnocercus) and crab-eating fox (Cerdocyon thous) from the Southern region of Brazil to Canine distemper virus (CDV), Canine parvovirus (CPV) and Canine coronavirus (CCoV)

The exposure of 13 Brazilian free-ranging nondomestic canids (five pampas fox - Pseudalopex gymnocercus and eight crab-eating fox -Cerdocyon thous) from Southern region of Brazil, to Canine distemper virus (CDV), canine parvovirus (CPV) and Canine coronavirus (CCoV) was investigated. Antibodies against CDV were detected in 38.5 percent (5/13) of the samples. There were anti-CDV antibodies in 60 percent (3/5) of P. gymnocercus and in 25 percent (2/8) of C. thous. The frequency was higher among the adults and males. Eleven canids (84.6 percent) presented antibodies against CPV, 80 percent (4/5) were from P. gymnocercus and 87.5 percent (7/8) were from C. thous. There was no difference in positivity rate against CPV between gender and age. Antibodies against CCoV were detected in 38.5 percent (5/13) of the samples, with 60 percent (3/5) of positivity in P. gymnocercus and 25 percent (2/8) in C. thous. The frequency of antibodies against CCoV was higher among the adults and males. The study showed that these canids were exposed to CDV, CPV and CCoV.

Foi investigada a ocorrência de exposição em 13 canídeos não domésticos de vida livre (cinco graxains-do-campo - Pseudalopex gymnocercus e oito graxains-do-mato - Cerdocyon thous) da região sul do Brasil ao vírus da cinomose canina (CDV), parvovírus canino (CPV) e coronavírus canino (CCoV). Anticorpos contra o CDV foram detectados em 38,5 por cento (5/13) das amostras. Haviam anticorpos anti-CDV em 60 por cento (3/5) dos P. gymnocercus e em 25 por cento (2/8) dos C. thous. A freqüência foi maior entre machos e adultos. Para CPV, 11 canídeos (84,6 por cento) apresentaram anticorpos, 80 por cento (4/5) eram da espécie P. gymnocercus e 87,5 por cento (7/8) eram C. thous. Não houve diferença de positividade para o CPV entre sexos e idades. Anticorpos contra o CCoV foram detectados em 38,5 por cento (5/13) das amostras, sendo 60 por cento (3/5) de positividade entre os P. gymnocercus e 25 por cento (2/8) entre os C. thous. A freqüência de anticorpos para CCoV foi maior entre os machos e adultos. O estudo revelou que estes canídeos foram expostos ao CDV, CPV e CCoV.

Development of a Polyclonal Antibody-based AC-ELISA and Its Comparison with PCR for Diagnosis of Canine Parvovirus Infection / 中国病毒学·英文版

A polyclonal antibody-based antigen-capture ELISA (AC-ELISA) has been developed for detection of Canine parvovirus (CPV) antigens in faecal samples of dogs. The assay uses rabbit anti-CPV polyclonal antibody as the capture antibody, guinea pig anti-CPV polyclonal antibody as tracing antibody and anti-guinea pig HRPO conjugate as the detection system. The optimum dilution of the capture antibody and the tracing antibody capable of detecting the CPV-2 antigens was found to be 1:1 600 and 1:400, respectively, in the check-board titration. In this study, a total of 152 samples (129 faecal samples and 23 cell culture supernatant) were tested both by AC-ELISA and by polymerase chain reaction (PCR). Of the samples tested, 69 and 78 samples were found positive by AC-ELISA and PCR, respectively. The AC-ELISA had relative sensitivity, relative specificity and accuracy of 88.4%, 100.0% and 91.4% respectively. The analytical sensitivity of AC-ELISA was estimated to be 102.8 TCID50/mL whereas PCR sensitivity was 100.8 TCID50/mL. The AC-ELISA is a simple, quick and reliable method for screening large numbers of faecal samples of dogs suspected of CPV infection.

Serological Survey for Canine Parvovirus Type 2a (CPV-2a) in the Stray Dogs in South Korea

Canine parvovirus type-2 (CPV-2) is one of the major diarrhea-causing agents, inducing acute hemorrhagic gastroenteritis in puppies. In this study, we conducted a seroepidemiological survey of CPV-2a in stray dogs in South Korea. In total, 405 canine sera, collected between 2006 and 2007, were screened for the presence of antibodies against CPV-2a using a hemagglutination inhibition (HI) assay. The positive rate in stray dogs tested for CPV-2a was 93.8%. The regional CPV-2a prevalence was 100% (8/8) in Jeju, 95.1% (232/244) in Gyeonggi, 94.7% (36/38) in Jeonra, 92.9% (13/14) in Gangwon, 92.7% (38/41) in Chungcheong, and 88.3% (53/60) in Gyeungsang province. No significant difference in the seropositive rate was found between male (93.6%) and female (94.0%) dogs. Analysis of the distribution of HI titer against CPV-2a according to the age of the stray dogs showed a linear increase in seroprevalence with age, although the association with age was not statistically significant. The incidence of stray dogs showing an HI antibody titer above 1:5120 was estimated to be 26.2%. Thus, the presence of high HI antibody against CPV-2a may indicate circulation of CPV-2a in stray dogs.

First detection of canine parvovirus type 2c in Brazil / Detecção de parvovírus canino tipo 2c no Brasil

The presence of canine parvovirus type 2 (CPV-2), 2a and 2b has been described in Brazil, however, the type 2c had not been reported until now. In the current study, seven out of nine samples from dogs with diarrhea were characterized as CPV-2c, indicating that this virus is already circulating in the Brazilian canine population.

No Brasil, a presença do parvovírus canino do tipo 2 (CPV-2), 2a e 2b já havia sido descrita, contudo, ainda não havia sido verificada a presença do tipo 2c. No presente trabalho, sete de nove amostras de cães com diarréia foram caracterizadas como CPV-2c, indicando que este vírus já está circulando na população canina no Brasil.

Análise imuno-histoquímica de cães naturalmente infectados pelo parvovírus canino / Immunohistochemical analysis of dogs infected naturally by canine parvovirus

Noventa e seis cães com lesões macroscópicas sugestivas de parvovirose canina foram necropsiados no Setor de Patologia Veterinária da Universidade Federal do Rio Grande do Sul no período de março de 2005 a novembro de 2006. Tecidos destes caninos foram analisados através de histologia e imuno-histoquímica. Aumento das placas de Peyer do intestino delgado e hiperemia da mucosa e serosa intestinal foram os achados macroscópicos mais observados. Microscopicamente, foi visualizada enterite necrótica em 77 por cento dos cães. Em 17,7 por cento as alterações histológicas do intestino delgado ficaram prejudicadas pela autólise, dificultando a interpretação. O teste de imuno-histoquímica em cortes de intestino delgado, linfonodo mesentérico, timo, baço, tonsila, língua e medula óssea de todos os 96 casos, foi positivo em 91,6 por cento (88/96) dos casos. O intestino delgado demonstrou o melhor resultado, obtendo-se marcações em 77 por cento (74/96) dos casos. A análise final do exame paramétrico de Fisher demonstrou uma fraca associação entre autólise intestinal e resultado positivo da imuno-histoquímica onde as chances de um intestino delgado autolisado histologicamente apresentar resultado positivo na imuno-histoquímica é 0,33 vezes menor (OR=0,33; 95 por centoIC: 0,10-1,17) quando comparada a um intestino delgado não autolisado.

Ninety-six dogs with gross lesions suggestive of canine parvovirus infection were selected and necropsied in the Faculty of Veterinary Medicine, Universidade Federal do Rio Grande do Sul, between March 2005 and November 2006. The main gross lesions were enlargement of the Peyer's patches in the small intestine and hyperemia in the intestinal mucosa and serosa. Microscopically, the small intestine showed necrotizing enteritis in 77 percent (74/96) of the dogs examined. However, in 17.7 percent of the histological evaluation in the small intestine were damaged due to autolytic changes making it difficult to obtain an appropriate interpretation. The immunohistochemistry test was performed in tissues of small intestine, mesenteric lymph nodes, thymus, spleen, tonsils, tongue, and bone marrow in all the 96 selected cases. Parvovirus antigen was detected in 91.6 percent (88/96) of the dogs necropsied. The best result of the IHC test was seen in samples of small intestine which was positive in 77 percent (74/96) of the cases. The statistical analysis (Fisher test) showed a weak association between intestinal autolysis and positive result of the IHC test. The chance of the autolysed intestine showing a positive result in the immunohistochemistry test was 0.33 less (OR=0.33, 95 percent CI:0.10-1.17) when compared with small intestine not autolysed.

Diagnóstico e estudo sorológico da infecção pelo parvovírus canino em cães de Passo Fundo, Rio Grande do Sul, Brasil / Diagnosis and serological study of canine parvovirus infection in dogs from Passo Fundo, Rio Grande do Sul, Brazil

A reação em cadeia da polimerase (PCR) e o ensaio de hemaglutinação (HA) foram comparados para a identificação de parvovírus canino (CPV) em fezes de cães com gastrenterite. A prevalência de anticorpos anti-CPV em uma população de cães sem histórico de vacinação foi avaliada pelo ensaio de inibição da hemaglutinação (HI). A variabilidade fenotípica entre uma amostra vacinal e isolados de campo foi investigada utilizando soro hiperimune. Trinta amostras fecais foram obtidas de cães com diarréia e submetidas à PCR e ao HA, e 185 amostras de soro de cães foram submetidas à HI para detectar anticorpos anti-CPV. Considerando-se somente como positivas as amostras que apresentaram HA na diluição igual ou superior a 1:64, detectou-se CPV em 9 (30 por cento) das amostras fecais. Nove amostras fecais apresentaram HA nas diluições entre 1:2 e 1:32 e foram consideradas negativas nesse teste. Todas as amostras que apresentaram HA na diluição igual ou superior a 1:64 foram positivas pela PCR e, das nove amostras que apresentaram HA nas diluições entre 1:2 e 1:32, seis também foram positivas para CPV na amplificação pela PCR. A pesquisa sorológica de amostras de soros caninos indicou que 178 (96,2 por cento) cães tiveram contato prévio com o vírus. Os soros hiperimunes produzidos em cobaias contra a cepa vacinal e dois isolados de campo indicaram possíveis diferenças fenotípicas entre isolados.

The polymerase chain reaction (PCR) and hemaglutination (HA) assay were used to detect canine parvovirus (CPV) in feces from young dogs with gastroenteritis. The hemaglutination inhibition (HI) assay was used to detect the prevalence of anti-CPV antibodies in a non-vaccinated dog population. In addition, hiperimmune serum was used to investigate the phenotypic variability of a vaccine strain and two field isolates of CPV. Thirty fecal samples obtained from dogs with diarrhea were submitted to PCR and HA, and 185 serum samples were submitted to HI to detect anti-CPV antibodies. Nine (30 percent) of the samples demonstrated HA on fecal dilutions equal to or above 1:64 and were considered positive by this test; nine (30 percent) fecal samples had HA activity on dilution from 1:2 to 1:32 and were considered negative, and the remaining samples were negative. All samples with HA activity at dilutions above 1:64 were also positive to PCR and, out of the nine samples with HA activity at dilutions between 1:2 and 1:32, six were also positive by PCR. Serological analysis of the dog serum samples indicated that 178 (96,2 percent) of the dogs had previous contact with the virus. Hiperimmune serum indicated possible phenotypic differences among isolates, in that different HI titers were obtained following cross-HI assay.

Níveis de anticorpos contra o vírus da cinomose canina e o parvovírus canino em cães não vacinados e vacinados / Antibodies levels against canine distemper virus and canine parvovirus in vaccinated and unvaccinated dogs

Antibody titres to canine distemper virus (CDV) and canine parvovirus (CPV) were measured in 132 dogs: 80 had been vaccinated at least once, 22 had not been vaccinated, and 30 had unknown vaccination history. Serum antibody titers were measured by means of serum neutralization (CDV) or hemagglutination inhibition (CPV). Serum CDV titers >20 and serum CPV titers >80 were considered protective. Protective antibodies to CDV were present in 40.1 percent of the population: 39.8 percent of the vaccinated dogs, 31.8 percent unvaccinated, and in 46.6 percent of the dogs with unknown vaccination history. Protective antibodies to CPV were present in 90.9 percent of the dogs: 93.7 percent of the vaccinated dogs, 90.9 percent of the unvaccinated, and 83.3 percent of the dogs with unknown vaccination history.